Publications by authors named "Salim Mujais"

Claim this Profile
C
Clinically Meaningful Improvements With Vibegron in Men With Overactive Bladder and Benign Prostatic Hyperplasia: A Responder Analysis of the Phase 3 COURAGE Trial.
Kenneth M Peters, Janet Owens-Grillo, Elizabeth Thomas, David Staskin, Eric S Rovner, Salim Mujais

Urology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bladder Function and Safety of Vibegron in Men With Overactive Bladder Receiving Treatment for Benign Prostatic Hyperplasia: Outcomes From the Phase 3 Randomized Controlled COURAGE Trial.
Eric S Rovner, Janet Owens-Grillo, Elizabeth Thomas, Sender Herschorn, Kenneth M Peters, Salim Mujais

Neurourol Urodyn· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene Therapy With URO-902 (pVAX/) for the Treatment of Female Patients With Overactive Bladder and Urge Urinary Incontinence: Safety and Efficacy From a Randomized Phase 2a Trial.
Ekene A Enemchukwu, Susan Kalota, Kaiser Robertson, Sijian Ge, Jingmei Lu, Salim Mujais

J Urol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial.
David Staskin, Janet Owens-Grillo, Elizabeth Thomas, Eric Rovner, Kevin Cline, Salim Mujais

J Urol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary on: Pharmacist-driven interventions to de-escalate urinary antimuscarinics in the Program of All-Inclusive Care for the Elderly.
Daniel Snyder, Salim Mujais

J Am Geriatr Soc· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: Pharmacist-driven interventions to de-escalate urinary antimuscarinics in the Programs of All-Inclusive Care for the Elderly.
Daniel Snyder, Salim Mujais

J Am Geriatr Soc· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi.
Amit V Desai, Laura L Kovanda, William W Hope, David Andes, Johan W Mouton, Salim Mujais

Antimicrob Agents Chemother· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial to investigate the effect of renal impairment on isavuconazole pharmacokinetics.
Robert W Townsend, Shahzad Akhtar, Harry Alcorn, Jolene K Berg, Donna L Kowalski, Salim Mujais

Eur J Clin Pharmacol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population Pharmacokinetics of Isavuconazole in Subjects with Mild or Moderate Hepatic Impairment.
Amit Desai, Anne-Hortense Schmitt-Hoffmann, Salim Mujais, Robert Townsend

Antimicrob Agents Chemother· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the safety, tolerability, and pharmacokinetics of fidaxomicin in healthy Japanese and caucasian subjects.
Hiroyuki Oshima, Takao Yamazaki, Lauren Benner, Takashi Miki, Ingrid Michon, Salim Mujais

Clin Drug Investig· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucoregulatory hormones and choice of osmotic agent in peritoneal dialysis.
Salim Mujais, Shruti N Tapiawala, Paul Yip, Fadel Al-Rowaie, Dorothy Burdzy

Perit Dial Int· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic effects of incremental doses of intraperitoneal amino acids on automated peritoneal dialysis.
Brendan B McCormick, Salim Mujais, Francine Poirier, Nicole Page, Susan Lavoie

Perit Dial Int· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in CKD Patients: correlates and evolution over time.
Salim K Mujais, Ken Story, John Brouillette, Tomoko Takano, Steven Soroka

Clin J Am Soc Nephrol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective evaluation of renal replacement therapy modality eligibility.
David C Mendelssohn, Salim K Mujais, Steven D Soroka, John Brouillette, Tomoko Takano

Nephrol Dial Transplant· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life and hemoglobin levels in chronic kidney disease patients.
Fredric O Finkelstein, Kenneth Story, Catherine Firanek, David Mendelssohn, Paul Barre, Salim Mujais

Clin J Am Soc Nephrol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceived knowledge among patients cared for by nephrologists about chronic kidney disease and end-stage renal disease therapies.
Fredric O Finkelstein, Kenneth Story, Catherine Firanek, Paul Barre, Tomoko Takano, Salim Mujais

Kidney Int· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison between bicarbonate/lactate and standard lactate dialysis solution in peritoneal transport and ultrafiltration: a prospective, crossover single-dwell study.
Wei Fang, Robert Mullan, Hemal Shah, Salim Mujais, Joanne M Bargman

Perit Dial Int· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What are the problems with using the peritoneal membrane for long-term dialysis?
Joanne M Bargman, Raymond T Krediet, Wai Kei Lo, Rafael Selgas, Gloria del Peso, Salim Mujais

Semin Dial· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of brain natriuretic peptides in patients on peritoneal dialysis: results from the ADEMEX trial.
Ramon Paniagua, Dante Amato, Salim Mujais, Edward Vonesh, Alfonso Ramos

Clin J Am Soc Nephrol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADEMEX: the evidence and the nephrosopher.
Salim Mujais, Edward Vonesh

Perit Dial Int· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why is the evidence favoring hemodialysis over peritoneal dialysis misleading?
John Burkart, Beth Piraino, Hoda Kaldas, Ji-Yang Sophie Lee, Filitsa H Bender, Salim Mujais

Semin Dial· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving cycler prescriptions in peritoneal dialysis through informatic profiling.
Salim Mujais, Ken Story

Adv Chronic Kidney Dis· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peritoneal dialysis-related infections recommendations: 2005 update.
Beth Piraino, George R Bailie, Judith Bernardini, Elisabeth Boeschoten, Amit Gupta, Salim Mujais

Perit Dial Int· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients.
Ya-Chen Tina Shih, Amy Guo, Paul M Just, Salim Mujais

Kidney Int· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life predicts outcomes but is not affected by peritoneal clearance: The ADEMEX trial.
Ramon Paniagua, Dante Amato, Edward Vonesh, Amy Guo, Salim Mujais

Kidney Int· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis